HR467-118

Passed House

To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

118th Congress Introduced Jan 24, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Trade, Criminal Justice.

Who Benefits and How

federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H5A8CF7A047D9411B98F6CE872BE346C7: 1. Short title This Act may be cited as the Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act.
  • Section H7FB25967C72D4C36B30CB40B20BB8722: 2. Class scheduling of fentanyl-related substances Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of...
  • Section HE11DA0432FDC4808B7B2B29B5C14B6A3: 3. Registration requirements related to research Section 303 of the Controlled Substances Act (21 U.S.C. 823) is amended— by redesignating the second...
  • Section H5A6E21F9665E4616A43845E0F99B872C: 4. Rulemaking The Attorney General— shall, not later than 6 months after the date of enactment of this Act, issue rules to implement this Act and the...
  • Section HE1EBA402EFDF40A3A765F6C413484BF3: 5. Penalties Section 401(b)(1) of the Controlled Substances Act (21 U.S.C. 841(b)(1)) is amended— in subparagraph (A)(vi), by inserting or a fentanyl-related...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Key Policy Areas

Government Operations, Trade, Criminal Justice

Primary Purpose

This bill, To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Policy Domains

Government Operations Trade Criminal Justice

Whole bill

Identified Gains
  • federal agencies and legislative administrators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: eh
federal agencies and legislative administrators: ,
Identified Costs
  • federal implementing agencies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: eh
federal implementing agencies: ,

Legislative Progress

Passed House
Introduced Committee Passed
May 30, 2023

Received; read twice and referred to the Committee on the …

May 30, 2023 (inferred)

Passed House (inferred from eh version)

May 17, 2023

Additional sponsors: Mr. Pfluger, Mr. Armstrong, Mr. Pence, Mr. Austin …

May 17, 2023

Reported from the Committee on Energy and Commerce with an …

May 17, 2023

Committee on the Judiciary discharged; committed to the Committee of …

Jan 24, 2023

Mr. Griffith (for himself, Mr. Latta, Mrs. Rodgers of Washington, …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
33 mentions across 13 clauses
+22 positive -11 negative

Attorney General / DOJ, DEA, DEA registration administration

Positive-direction: DEA, Department of Defense research programs, Federal prosecutors, Law enforcement, Law enforcement agencies, Veterans Affairs research programs

Negative-direction: Attorney General / DOJ, DEA registration administration, DOJ Inspector General

Research & Science
8 mentions across 4 clauses
+8 positive

Medical researchers, NIH-funded researchers

Manufacturing
4 mentions across 4 clauses
-4 negative

Fentanyl analog manufacturers and traffickers

Pharmaceuticals
4 mentions across 4 clauses
-4 negative

Pharmaceutical companies with fentanyl-related R&D

Educational Services
4 mentions across 4 clauses
+4 positive

Research universities

Illicit Drug Trafficking
2 mentions across 1 clause
-2 negative

Drug importers and exporters, Fentanyl analog traffickers

General Public
1 mention across 1 clause
-1 negative

Criminal defendants in fentanyl cases

6/6
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Government Operations Trade Criminal Justice
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology